<html>
<head>PUBMED IDs for ZSCAN1</head>
<body bgcolor='#C5F0F2'><h1>ZSCAN1</h1><a href='https://pubmed.ncbi.nlm.nih.gov/21132003/'>Genome-wide methylation analysis identifies epigenetically inactivated candidate tumour suppressor genes in renal cell carcinoma.</a> May 19  2010<br><a href='https://pubmed.ncbi.nlm.nih.gov/22983262/'>Novel target genes and a valid biomarker panel identified for cholangiocarcinoma.</a> April 17  2012<br><a href='https://pubmed.ncbi.nlm.nih.gov/24948044/'>The novel colorectal cancer biomarkers CDO1, ZSCAN18 and ZNF331 are frequently methylated across gastrointestinal cancers.</a> February 15  2014<br><a href='https://pubmed.ncbi.nlm.nih.gov/27460080/'>Systemic transcriptome analysis of hepatocellular carcinoma.</a> July 28  2016<br><a href='https://pubmed.ncbi.nlm.nih.gov/28111342/'>Development of a highly specific HER2 monoclonal antibody for immunohistochemistry using protein microarray chips.</a> January 24  2017<br><a href='https://pubmed.ncbi.nlm.nih.gov/28167242/'>Epigenome-Wide DNA Methylation Profiling Identifies Differential Methylation Biomarkers in High-Grade Bladder Cancer.</a> February 8  2017<br></body></html>
